 |
0 Diseases |  |
643 Trials |
|
643 Trials |  |
26774 News |  |
| «12...510511512513514515516517518519520521522 |
- bortezomib / Generic mfg., doxorubicin hydrochloride / Generic mfg.
Trial termination, Metastases: Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer (clinicaltrials.gov) - Aug 7, 2011
P2, N=4, Terminated, Sponsor: University of Wisconsin, Madison
Suspended --> Terminated; no additional funding
- | Rituxan (rituximab) / Roche
New P2 trial: S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma (clinicaltrials.gov) - Aug 7, 2011
P2, N=180, Recruiting, Sponsor: Southwest Oncology Group
- Campath (alemtuzumab) / Sanofi
Enrollment closed, IO biomarker: CHOP and Campath-1H in Previously Untreated Aggressive T/NK-Cell Lymphomas (clinicaltrials.gov) - Aug 7, 2011
P1, N=24, Active, not recruiting, Sponsor: Ohio State University Comprehensive Cancer Center
Suspended --> Terminated; no additional funding Recruiting --> Active, not recruiting